Cherry et al. alsoexamined CCL21 levels between CTE-confirmed and AD-confirmed subjects viapost-mortem CSF analysis, showing that there was a significant elevation of CCL21levels in AD (22). The gene discussed is CCL21; the disease is Alzheimer disease.